補助人工心臓の世界市場レポート 2025年

補助人工心臓市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.1％で39億1,000万米ドルに成長します。予測期間の成長は、目的地治療のニーズの高まり、高齢化、ヘルスケア支出の増加、心不全治療に関する意識の高まりに起因すると考えられます。予測期間の主な動向には、補助人工心臓の有効寿命延長への注力、補助人工心臓の小型化、ポンプ技術の進歩、VADの安全性と有効性への注目の高まり、補助人工心臓の副作用軽減への注力、経皮的挿入型補助人工心臓などがあります。

心血管疾患の有病率の上昇が補助人工心臓市場の成長を促進しています。心血管障害には、高血圧、喫煙、高コレステロール、運動不足などの要因によって引き起こされる心臓病が含まれ、ますます一般的になっています。これらの疾患の有病率は、糖尿病、慢性呼吸器疾患、高血圧に関連した心臓発作などの非感染性疾患によってさらに悪化しています。心血管障害の発生率が上昇するにつれて、重症の心臓病患者にとって重要な支援システムとなる補助人工心臓の需要も増加しています。例えば、2022年10月、米国の連邦機関である国立医学図書館は、2035年までに米国人口の45.1％が心血管疾患に罹患し、これらの疾患に関連する総費用は1兆1,000億米ドルに達すると予測しています。その結果、心血管疾患の有病率の増加は、予測期間中に補助人工心臓の需要を大幅に押し上げると予想されます。

心不全治療をめぐる意識の高まりは、補助人工心臓市場の成長を促進すると予想される極めて重要な要因です。心不全は、心臓が血液を効果的に送り出す能力が低下することを特徴とし、冠動脈疾患、心臓発作、高血圧、心筋損傷などの病態に起因します。心不全治療に対する意識の高まりは、心不全に対処する手段として補助人工心臓の採用を促進すると予想されます。特に米国心臓協会は、2030年までに心不全の診断が46％増加し、罹患者数が800万人を超えると予測しています。心不全と診断される人の数が増加し続ける中、利用可能な治療オプションに対する意識の高まりが、補助人工心臓市場の主要な促進要因になると予測されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界補助人工心臓PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の補助人工心臓市場：成長率分析
• 世界の補助人工心臓市場の実績：規模と成長, 2019-2024
• 世界の補助人工心臓市場の予測：規模と成長, 2024-2029, 2034F
• 世界補助人工心臓総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の補助人工心臓市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 左心室補助装置（LVAD）
• 右心室補助装置（RVAD）
• 両心室補助装置（BIVAD）
• 世界の補助人工心臓市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脈動流
• 連続フロー
• 世界の補助人工心臓市場：設計別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮的心室補助装置
• 埋め込み型補助人工心臓
• 世界の補助人工心臓市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブリッジ・トゥ・トランスプラント（BTT）療法
• デスティネーションセラピー
• 回復への橋渡し（BTR）療法
• ブリッジ・トゥ・キャンディダシー（BTC）療法
• 世界の補助人工心臓市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 心臓病センター
• 世界の補助人工心臓市場左心室補助装置（LVAD）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 埋め込み型LVAD
• 一時的LVAD
• 世界の補助人工心臓市場右心室補助装置（RVAD）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 埋め込み型RVAD
• 一時的なRVAD
• 世界の補助人工心臓市場、両心室補助装置（BIVAD）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルサポートBIVAD
• ハイブリッド BIVAD

第7章 地域別・国別分析

• 世界の補助人工心臓市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の補助人工心臓市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 補助人工心臓市場：競合情勢
• 補助人工心臓市場：企業プロファイル
  • Abiomed Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Overview, Products and Services, Strategy and Financial Analysis
  • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Berlin Heart GmbH
• Cirtec
• Jarvik Heart Inc.
• SynCardia Systems LLC.
• Calon Cardio-Technology Ltd
• Huadong Medicine Co. Ltd
• Shenzhen Hexin Zondan Medical Equipment Co. Ltd
• Sun Medical Technology Research Corp.
• Boston Scientific Corporation
• CorWave SA
• CH Biomedical（USA）Inc
• Evaheart Inc
• BiVACOR Inc
• ReliantHeart Inc
• Cardiac Assist Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 補助人工心臓市場2029：新たな機会を提供する国
• 補助人工心臓市場2029：新たな機会を提供するセグメント
• 補助人工心臓市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A ventricular assist device (VAD) is an implantable mechanical circulatory device used to treat heart failure by aiding blood circulation throughout the body, supporting vital organ function. The US FDA has approved a diverse range of VADs, offering long-term or permanent assistance for patients with end-stage heart failure.

The primary types of VADs include left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). LVADs, battery-operated mechanical pumps, help propel blood from the left ventricle to vital organs. They vary in design as transcutaneous or implantable devices and operate with different flow mechanisms such as pulsatile flow and continuous flow. These devices are used for various purposes including bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. End-users of VADs include hospitals, ambulatory surgical centers, and cardiology centers.

The ventricular assist device market research report is one of a series of new reports from The Business Research Company that provides ventricular assist device market statistics, including ventricular assist device industry global market size, regional shares, competitors with a ventricular assist device market share, detailed ventricular assist device market segments, market trends and opportunities, and any further data you may need to thrive in the ventricular assist device industry. This ventricular assist device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ventricular assist device market size has grown rapidly in recent years. It will grow from $2.12 billion in 2024 to $2.39 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to an increase in the prevalence of heart failure and a rise in demand for organ transplantation procedures.

The ventricular assist device market size is expected to see rapid growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to the increasing need for destination therapy, aging population, increasing healthcare expenditure and a rise in awareness regarding heart failure treatment. Major trends in the forecast period include focus on lengthening effective life of VADs, miniaturization of VADs, advanced pump technologies, increased focus on VAd safety and effectiveness, focus on reduction in side effects of VADs and percutaneously inserted ventricular assist devices.

The rising prevalence of cardiovascular disorders is driving growth in the ventricular assist device market. Cardiovascular disorders, which include heart diseases caused by factors such as high blood pressure, smoking, high cholesterol, and inactivity, are increasingly common. The prevalence of these conditions is further exacerbated by non-communicable diseases like diabetes, chronic respiratory illnesses, and heart attacks linked to hypertension. As the incidence of cardiovascular disorders rises, so does the demand for ventricular assist devices, which serve as crucial support systems for severely ill cardiac patients. For instance, in October 2022, the National Library of Medicine, a US-based federal agency, projected that by 2035, 45.1% of the US population will have cardiovascular disease, with total costs associated with these diseases expected to reach $1.1 trillion. Consequently, the increasing prevalence of cardiovascular disorders is anticipated to significantly boost demand for ventricular assist devices during the forecast period.

The increased awareness surrounding heart failure treatment is a pivotal factor expected to fuel the growth of the ventricular assist device market. Heart failure, characterized by the heart's diminished ability to effectively pump blood, can result from conditions such as coronary artery disease, heart attacks, high blood pressure, and heart muscle damage. The escalating awareness about heart failure treatments is anticipated to drive the adoption of ventricular assist devices as a means to address heart failure. Notably, the American Heart Association projects a 46% increase in heart failure diagnoses by 2030, surpassing 8 million individuals affected. As the number of people diagnosed with heart failure continues to rise, the heightened awareness of available treatment options is poised to be a key driver for the ventricular assist device market.

The adoption of percutaneously inserted ventricular assist devices is gaining prominence in the market. Percutaneously inserted ventricular assist devices are non-pulsatile axial flow pumps positioned across the aortic valve, pumping blood from the left ventricle. These devices alleviate the load on the left ventricle, decrease myocardial oxygen consumption, enhance cardiac output, and reduce left ventricular end-diastolic pressure. As an example, in August 2022, Abiomed Inc., a US-based medical device company, introduced the Impella, a percutaneous VAD designed for eligible pediatric patients in the USA. The Impella device provides effective cardiac support to compensate for a failing left ventricle and can serve as an alternative to extracorporeal membrane oxygenation (ECMO) or complement other therapies to enhance hemodynamics.

In August 2022, Medtronic PLC, an Ireland-based medical device company, acquired Affera, Inc. for $925 million. This strategic acquisition broadens Medtronic's portfolio of cardiac ablation products, introducing their initial cardiac mapping and navigation platform. The platform includes radiofrequency ablation, focal pulsed field, and an integrated diagnostic solution. Affera Inc., a US-based medical technology company, specializes in cardiac mapping and navigation systems, along with catheter-based cardiac ablation technologies.

Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ventricular assist device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The ventricular assist device market consists of sales of pulsatile and nonpulsatile LVADs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventricular Assist Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ventricular assist device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventricular assist device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ventricular assist device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).
• 2) By Type: Pulsatile Flow, Continuous Flow
• 3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
• 4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
• 5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres
• Subsegments:
• 1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs; Temporary LVADs
• 2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs; Temporary RVADs
• 3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs; Hybrid BIVADs
• Companies Mentioned: Abiomed; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ventricular Assist Device Market Characteristics

3. Ventricular Assist Device Market Trends And Strategies

4. Ventricular Assist Device Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Ventricular Assist Device Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ventricular Assist Device PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ventricular Assist Device Market Growth Rate Analysis
• 5.4. Global Ventricular Assist Device Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ventricular Assist Device Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ventricular Assist Device Total Addressable Market (TAM)

6. Ventricular Assist Device Market Segmentation

• 6.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)
• 6.2. Global Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulsatile Flow
• Continuous Flow
• 6.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices
• 6.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bridge-to-Transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-Recovery (BTR) Therapy
• Bridge-to-Candidacy (BTC) Therapy
• 6.5. Global Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Cardiology Centers
• 6.6. Global Ventricular Assist Device Market, Sub-Segmentation Of Left Ventricular Assist Devices (LVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable LVADs
• Temporary LVADs
• 6.7. Global Ventricular Assist Device Market, Sub-Segmentation Of Right Ventricular Assist Devices (RVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable RVADs
• Temporary RVADs
• 6.8. Global Ventricular Assist Device Market, Sub-Segmentation Of Biventricular Assist Devices (BIVADs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Full Support BIVADs
• Hybrid BIVADs

7. Ventricular Assist Device Market Regional And Country Analysis

• 7.1. Global Ventricular Assist Device Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ventricular Assist Device Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ventricular Assist Device Market

• 8.1. Asia-Pacific Ventricular Assist Device Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ventricular Assist Device Market

• 9.1. China Ventricular Assist Device Market Overview
• 9.2. China Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ventricular Assist Device Market

• 10.1. India Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ventricular Assist Device Market

• 11.1. Japan Ventricular Assist Device Market Overview
• 11.2. Japan Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ventricular Assist Device Market

• 12.1. Australia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ventricular Assist Device Market

• 13.1. Indonesia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ventricular Assist Device Market

• 14.1. South Korea Ventricular Assist Device Market Overview
• 14.2. South Korea Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ventricular Assist Device Market

• 15.1. Western Europe Ventricular Assist Device Market Overview
• 15.2. Western Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ventricular Assist Device Market

• 16.1. UK Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ventricular Assist Device Market

• 17.1. Germany Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ventricular Assist Device Market

• 18.1. France Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ventricular Assist Device Market

• 19.1. Italy Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ventricular Assist Device Market

• 20.1. Spain Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ventricular Assist Device Market

• 21.1. Eastern Europe Ventricular Assist Device Market Overview
• 21.2. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ventricular Assist Device Market

• 22.1. Russia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ventricular Assist Device Market

• 23.1. North America Ventricular Assist Device Market Overview
• 23.2. North America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ventricular Assist Device Market

• 24.1. USA Ventricular Assist Device Market Overview
• 24.2. USA Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ventricular Assist Device Market

• 25.1. Canada Ventricular Assist Device Market Overview
• 25.2. Canada Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ventricular Assist Device Market

• 26.1. South America Ventricular Assist Device Market Overview
• 26.2. South America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ventricular Assist Device Market

• 27.1. Brazil Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ventricular Assist Device Market

• 28.1. Middle East Ventricular Assist Device Market Overview
• 28.2. Middle East Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ventricular Assist Device Market

• 29.1. Africa Ventricular Assist Device Market Overview
• 29.2. Africa Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ventricular Assist Device Market Competitive Landscape And Company Profiles

• 30.1. Ventricular Assist Device Market Competitive Landscape
• 30.2. Ventricular Assist Device Market Company Profiles
  • 30.2.1. Abiomed Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Ventricular Assist Device Market Other Major And Innovative Companies

• 31.1. Berlin Heart GmbH
• 31.2. Cirtec
• 31.3. Jarvik Heart Inc.
• 31.4. SynCardia Systems LLC.
• 31.5. Calon Cardio-Technology Ltd
• 31.6. Huadong Medicine Co. Ltd
• 31.7. Shenzhen Hexin Zondan Medical Equipment Co. Ltd
• 31.8. Sun Medical Technology Research Corp.
• 31.9. Boston Scientific Corporation
• 31.10. CorWave SA
• 31.11. CH Biomedical (USA) Inc
• 31.12. Evaheart Inc
• 31.13. BiVACOR Inc
• 31.14. ReliantHeart Inc
• 31.15. Cardiac Assist Inc

32. Global Ventricular Assist Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ventricular Assist Device Market

34. Recent Developments In The Ventricular Assist Device Market

35. Ventricular Assist Device Market High Potential Countries, Segments and Strategies

• 35.1 Ventricular Assist Device Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ventricular Assist Device Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ventricular Assist Device Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer